Thai FDA (TFDA) — Thailand's Medical Device Regulator
Medical devices in Thailand are regulated by the Thai Food and Drug Administration (TFDA) under the Ministry of Public Health, governed by the Medical Device Act B.E. 2551 (2008). The TFDA classifies medical devices into three classes based on risk level, each with distinct regulatory pathways.
Class 1 devices (low risk) are subject to a notification process rather than full registration — the manufacturer or importer notifies the TFDA and receives acknowledgement, typically within 30 to 60 days. Class 2 devices (moderate risk) require a formal product licence from the TFDA, involving technical review. Class 3 devices (high risk, including implantable and life-sustaining devices) require a full product licence with factory inspection of the manufacturing site.
Critically, all foreign medical devices entering Thailand must be imported through a licensed importer holding a valid Import Licence issued by the TFDA. This is separate from the product registration and must be secured before any commercial supply. JNPMEDI APAC coordinates both the product registration and import licence processes for seamless market entry.
- Medical Device Act B.E. 2551 (2008) — primary legislation
- Class 1: Notification · Class 2: Licence · Class 3: Licence + factory inspection
- Import Licence required for all foreign medical devices
- Licensed importer (local entity) required for all market supply
- Post-market adverse event reporting mandatory
TFDA Review Timelines by Device Class
Estimated TFDA processing times from submission. Class 3 timelines may be extended if a factory inspection is required. Import Licence processing runs in parallel with product registration.
Integrated Services for Thailand TFDA Registration
TFDA Device Registration
Full management of Class 1 notification through Class 3 licence applications — including technical dossier preparation in TFDA-required format, submission coordination, deficiency response, and approval tracking. Factory inspection coordination and support for Class 3 high-risk devices included where required.
Import Licence Coordination
Securing the TFDA Import Licence for your device is a prerequisite to any commercial supply in Thailand. JNPMEDI APAC coordinates Import Licence applications in parallel with product registration — ensuring you are commercially ready as soon as product approval is granted, with no additional delays.
Post-Market & Compliance
Ongoing post-market regulatory obligations in Thailand — adverse event reporting to TFDA, licence renewals, product variation management, and regulatory intelligence on TFDA guideline updates. Full lifecycle compliance management so your device remains market-ready throughout its commercial life.
Why JNPMEDI APAC for Thailand TFDA Registration
Thailand uniquely requires both product registration and a separate Import Licence before any device can be sold. Many regulatory consultants handle only one of these. JNPMEDI APAC manages both under a single engagement, coordinating timelines to ensure zero gap between approval and commercial readiness.
JNPMEDI APAC operates directly in Thailand with local regulatory capabilities — not through a third-party agent. This means faster deficiency response turnaround, accurate TFDA portal management, and real accountability on your submission timeline.
Thailand registration is often paired with Malaysia, Indonesia, or Vietnam for Southeast Asia market coverage. JNPMEDI APAC coordinates all three simultaneously — sharing core technical documentation, aligning submission timelines, and managing all three regulatory relationships through a single contract.
Thailand TFDA Registration — FAQ
Yes, every foreign medical device entering Thailand commercially requires a valid TFDA Import Licence. This is separate from product registration and must be secured before any first commercial shipment. JNPMEDI APAC coordinates both in parallel.
Class 2 requires a full product licence with technical review by TFDA. Class 3 devices (high-risk, implantable, life-sustaining) additionally require a factory inspection of the manufacturing site, which extends the timeline to 150–200 days.
TFDA has an abridged review process for devices with existing CE or FDA approvals in some categories, but this is not universally available. JNPMEDI APAC assesses your specific device's eligibility for a shortened pathway at the outset.
Yes. JNPMEDI APAC coordinates both markets under a single contract, maximizing dossier content reuse. Singapore, Malaysia, and Thailand are often the first-wave SEA markets for device manufacturers.